Found "Digital Medicine": 213 results
Panupong Chaowanasawat
Panupong Chaowanasawat is an Associate at the Health Intervention and Technology Assessment Program (HITAP). He holds a Bachelor of Science in Public Health (Honors) with a minor in Global Health and Social Medicine from Wayne State University, USA. His academic and professional background reflects a strong commitment to public health research and
OxyContin abuse down with time-release formula
(Reuters Health) – There’s more evidence that the new formulation of OxyContin, the time-release version of oxycodone, is discouraging abuse of the powerful drug.But the reformulation, introduced in August 2010 to make it harder to crush the medicine into powder, limiting the ability to snort, injec
Outcomes in Economic Evaluations of Public Health Interventions in Low- and Middle-Income Countries: Health, Capabilities and Subjective Wellbeing. (2016)
GIULIA GRECOa,*, PAULA LORGELLYb and INTHIRA YAMABHAIc
a London School of Hygiene & Tropical Medicine, London, UK
b Centre for Health Economics, Monash University, Melbourne, Victoria, Australia
c Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Bangko
Off-label medicines: Rational or Irrational?
The use of off-label medicines is an unexplored area for healthcare priority setting, though it is common practice in countries
and can have a significant positive or negative effect on health outcomes and the efficiency of health care systems.
It is therefore important to have a rational an
Novartis argues for Glivec patent at India’s top court
(Reuters) – Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the country’s healthcare sector.A patent would recognize Novartis’ property rights, i
New Novartis drug shows potential in heart failure
(Reuters) – An experimental drug from Novartis may help up to half of heart failure patients for whom no effective treatment is available, although the evidence so far is indirect.Results of a mid-stage clinical trial of the drug known as LCZ696, unveiled on Sunday, gauged its effectiveness by measu
Navigating the Landscape of Digital Health: United Kingdom
Digital health technologies (DHTs) represent various products used in the healthcare system, including software, applications (apps) and online platforms benefiting individuals and the wider health and social care system. It is a field characterised by complexity and dynamism.
The English digital
Navigating the Landscape of Digital Health: South Korea
Executive Summary
Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan
Navigating the Landscape of Digital Health: Singapore
Digital health interventions (DHIs), such as electronic decision support tools, telemonitoring, or mobile health (mHealth) apps, have the potential to address health system challenges that limit the achievement of universal health coverage (UHC).
Regional economic development and a growing ageing
Navigating the Landscape of Digital Health: Indonesia
Executive Summary
Digital health technology (DHT) offers the potential to expand universal health coverage (UHC) by answering healthcare needs through a wide range of technology applications for instance artificial intelligence, big data, and machine learning. The adoption of DHT is not a new con
10 / Page